A1 Viable and reliable vaccine
In the context of efforts to address the pandemic, one of the priorities of the Ministry of Health was to ensure that the country gets its share of the COVID-19 vaccine by following several steps, the most important of which is the formation of a working group to help provide a viable, reliable vaccine.
The group was headed by the Deputy Minister of Health for Health Affairs, with its other members including the Director General Disease Surveillance and Control, the Director General of Medical Supplies, the Director General of Primary Health Care, the General Director of Pharmacy and Drug Control, and the in addition to the Director of the Infectious Diseases Control Department.
The role of the group was defined under Ministerial Decision No. 120/2020, which states that the team is responsible for following up global developments in the field of manufacturing and producing an anti-coronavirus vaccine, and setting up methods to obtain the appropriate vaccine in coordination with the Global Alliance for Vaccines and Immunisation, the World Health Organization, and other companies providing this specialised service.
Experts and specialists may be sought by the team to this end, and the team’s leader is required to submit a report on the recommendations over choosing the appropriate vaccine from among those produced globally.
The arrival of the vaccine has been preceded by many steps, including the implementation of a nationwide questionnaire to poll public opinion about the COVID-19 vaccine, which is aimed at assessing the level of community awareness, attitudes and practices related to its presence in the Sultanate.
A digital surveillance and recovery programme to help administer the vaccine, and follow up with those who have received it has also been set up.
Several meetings were held at various levels, including between the Minister of Health and the Directors General across the governorates to discuss the implementation plan for the vaccine, in keeping with preparations to administer it to people.
Meetings were also held with directors of infectious disease control, and vaccination specialists across the country. A training programme for healthcare workers issuing the vaccine was also held.
Because this vaccine has to be preserved at temperatures of -80 degrees Celsius, maintaining the cold storage chain for it is one of the most basic requirements to ensure its retains its quality and is safe to use.
It was important to ensure the readiness of all the governorates for storing the vaccine, after all of the required logistical support was provided as part of the national campaign for COVID-19 immunisation, which included the provision of ultra-low temperature thermal fridges to maintain steady temperatures.